GlobalRPH - Arthritis News

Medical News

< back to feeds
Arthritis News (Page 9)
Flexcin Offers Tips To Minimize Summertime Arthritis Most people think arthritis is worse in the cold, winter months but a dirty little secret is that it can be just as painful during the hot, summer months as well. Paying close attention to your diet and exercising the right way can help minimize the pain. Flexcin International, Inc., a natural supplement company offering the only ...more	31 July 2009
Sun Exposure May Trigger Certain Autoimmune Diseases In Women Ultraviolet (UV) radiation from sunlight may be associated with the development of certain autoimmune diseases, particularly in women, according to a study by researchers at the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health. ...more	31 July 2009
Protein Level May Serve As Predictor Of Severe Osteoarthritis Osteoarthritis (OA), the most common joint disorder throughout the world and a leading cause of disability, is characterized by pain, impaired joint mobility, reduction of muscular strength and loss of joint function. Unlike most other common diseases, little is known about its origins, and factors predicting a severe disease course have not been identified. ...more	31 July 2009
Rheumatoid Arthritis Is Worse In Poorer Countries People in less affluent countries appear to suffer from more severe rheumatoid arthritis (RA) than people in wealthy countries, suggests research published ahead of print in the Annals of the Rheumatic Diseases. A study of 25 mostly European countries showed that the clinical status of patients with RA was inversely correlated with each country's gross domestic product (GDP). ...more	30 July 2009
Using Ultrasound To Detect Early Signs Of Osteoarthritis Researchers at The University of Nottingham are hoping to find out if inflammation of the knee could be an early sign of osteoarthritis - a condition which leads to pain, stiffness, swelling and disability. Up to six million people in the UK suffer from osteoarthritis in the knee. ...more	25 July 2009
Disease Markers That Will Aid Arthritis Research A combination of biochemical and MRI markers will allow improved measurement of osteoarthritis (OA) progression. The biomarkers, described in BioMed Central's open access journal Arthritis Research and Therapy, will be useful for the design and interpretation of trials of new disease modifying drugs. Erik Dam, from Nordic Bioscience, Denmark, worked with a team of researchers to develop and evaluate the markers. ...more	25 July 2009
Health Care Reform A Priority For People With Arthritis The Arthritis Foundation supports health care reform, which provides universal and affordable health care for the 46 million Americans living with arthritis. American families, both insured and uninsured, are struggling with rising health care costs - and the number of uninsured is rising. ...more	24 July 2009
Osteoarthritis A Major Consequence Of Obesity Epidemic, Claims Charity In New Report Obese people are four times as likely to develop osteoarthritis of the knee as they are to develop high blood pressure or type-2 diabetes, according to a leading arthritis charity, launching a new online report on the subject. But whereas high blood pressure and diabetes may be substantially improved on losing weight and are relatively easy to control with therapy, the changes resulting from osteoarthritis are irreversible, as worn cartilage cannot currently be repaired. ...more	22 July 2009
Lupus Drug Benlysta Effective In Phase 3 Trials In what has been described as the first lupus drug in decades to show effectiveness in phase 3 clinical trials, the announcement that Benlysta (belimumab) outperformed placebo has surprised Wall Street, where many had assumed the drug was going nowhere. ...more	20 July 2009
Seminal Finding Has Major Implications For The Development Of New And Better Vaccines A research team led by the La Jolla Institute for Allergy & Immunology has identified the specific gene which triggers the body to produce disease-fighting antibodies -- a seminal finding that clarifies the exact molecular steps taken by the body to mount an antibody defense against viruses and other pathogens. The finding, published online today in the prestigious journal Science, has major implications for the development of new and more effective vaccines. ...more	18 July 2009
UAB Total Joint Replacement Research Collaboration Supported By New NIH Funding Newly announced National Institutes of Health (NIH) funding will expand the reach of ongoing University of Alabama at Birmingham (UAB) research into a unique nanostructured coating to improve the performance and longevity of total joint replacement components. The broadened UAB research opportunity is funded by a four-year, $790,931 National Institutes of Health (NIH) grant through the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). ...more	18 July 2009
Gene Regulates Immune Cells' Ability To Harm The Body A recently identified gene allows immune cells to start the self-destructive processes thought to underlie autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis, researchers at Washington University School of Medicine in St. Louis have found. Researchers showed that mice without the Batf gene lacked a type of inflammatory immune cell and were resistant to a procedure that normally induces an autoimmune condition similar to human MS. ...more	17 July 2009
Act On Official Audit, Arthritis Care Challenges 'Half-Hearted' Health Services, UK Arthritis Care, the UK's largest support charity for people with arthritis, welcomes the National Audit Office report into rheumatoid arthritis services and urges health chiefs to implement its recommendations as swiftly as possible. The audit highlights 'minimal' GP training in rheumatoid arthritis (RA) and poorly co-ordinated services, which the charity says means thousands of people with this devastating disease are failed by the system. ...more	16 July 2009
Study To Assess Hip Exercises As Treatment For Osteoarthritis In The Knee Joints Researchers at Rush University Medical Center are testing a novel regimen of hip-muscle exercises to decrease the load on the knee joints in patients with osteoarthritis. The goal is not only to relieve pain but also, possibly, to halt progression of the disease. "Each time you take a step, a load, or force, is placed on the knee joints. ...more	16 July 2009
Immune Cell Function Can Be Suppressed By Leading Pathogen In Newborns Group B Streptococcus (GBS), a bacterial pathogen that causes sepsis and meningitis in newborn infants, is able to shut down immune cell function in order to promote its own survival, according to researchers at the University of California, San Diego School of Medicine and the Skaggs School of Pharmacy and Pharmaceutical Sciences. ...more	14 July 2009
Potential Fix For Damaged Knees Identified By Study Investigators from Hospital for Special Surgery have shown that a biodegradable scaffold or plug can be used to treat patients with damaged knee cartilage. The study is unique in that it used serial magnetic resonance imaging (MRI) and newer quantitative T2 mapping to examine how the plug incorporated itself into the knee. The research, abstract 8372, was presented during the annual meeting of the American Orthopedic Society for Sports Medicine, June 9-12, in Keystone, Colo. ...more	11 July 2009
What Is a Ganglion? What Is a Ganglion Cyst? Ganglion cysts are fluid-filled swellings that tend to form on top of joints or tendons in the wrists, hands, and feet. They have the appearance of firm or spongy sacs of liquid and their insides consist of a sticky, clear, thick, jelly-like fluid. Ganglion cysts are idiopathic, which means they generally form for unknown reasons. As painless and benign (not dangerous) growths, ganglion cysts often do not require treatment and go away on their own. ...more	10 July 2009
Array BioPharma Announces Top-Line Results In Two Phase 1 Clinical Trials Array BioPharma Inc. (NASDAQ: ARRY) announced top-line results from its Phase 1 seven-day dose escalation trial up to 1,200 mg daily of p38 inhibitor, ARRY-797, in healthy volunteers. In addition, the top-line results were announced in a second study, where ARRY-797 was evaluated in a 28-day Phase 1b trial in stable rheumatoid arthritis (RA) patients taking methotrexate. This study compared two doses of ARRY-797 to placebo. ...more	10 July 2009
Millions Of People With Musculoskeletal Conditions At Risk Of Being Let Down By NHS One-in-five (21%) primary care trusts (PCTs) do not offer 'clinical assessment and treatment services' (CATS) for people with musculoskeletal conditions, denying them services deemed a 'keystone' of the government's 2006 musculoskeletal services strategy1. ...more	10 July 2009
Thiarabine Demonstrates A Reduction Of Both Inflammatory And Erosive Disease Parameters In Rheumatoid Arthritis ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced new preclinical data demonstrating that thiarabine shows remarkable efficacy in the prevention and treatment of rheumatoid arthritis (RA). In a well-established animal model for RA, an exceptional restoration of joint structure was observed in the studies, which were conducted at Wayne State University School of Medicine and at Southern Research Institute. ...more	08 July 2009
Pages of Results: [First Page] [Prev] 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 [Next] [Last Page]
Arthritis News courtesy of Medical News Today	back to top

Medical News

Looking for a Job?

Career Center

Popular Tools

Disclaimer Contact Us Privacy Policy Website Search	We comply with the HONcode standard for health trustworthy information: Verify here. Copyright © 2007 GlobalRPh Inc.